Incorporating Filastatin into medical plastics to minimize nosocomial fungal infections
PublicDownloadable Content
open in viewerThe cost of treating a Candida albicans infection for urinary catheters exceeds $200 million per year due to increasing resistance to antifungal drugs. Using a small molecule called Filastatin that affects cell morphology, we developed several approaches to integrate the molecule into silicone catheters to prevent cell adhesion. Utilizing a cell adhesion assay, we screened the various designs to classify which had the greatest impact on preventing cell adhesion. We found through testing that absorption of the molecule had the most influence compared to the other alternatives. In addition, we determined through a cost analysis that this method could be cheaper compared to what is currently on the market for antifungal catheters.
- This report represents the work of one or more WPI undergraduate students submitted to the faculty as evidence of completion of a degree requirement. WPI routinely publishes these reports on its website without editorial or peer review.
- Creator
- Publisher
- Identifier
- E-project-042816-135800
- Advisor
- Year
- 2016
- Sponsor
- Date created
- 2016-04-28
- Resource type
- Major
- Rights statement
Relations
- In Collection:
Items
Items
Thumbnail | Title | Visibility | Embargo Release Date | Actions |
---|---|---|---|---|
MQPpaper_Lipsky_Final.pdf | Public | Download |
Permanent link to this page: https://digital.wpi.edu/show/vx021g818